Lot-to-lot Consistency of Quadrivalent Influenza Vaccine (Split Virion), Inactivated

Clinical trial NCT05512494 · COMPLETED

Trial details

NCT number: NCT05512494
Sponsor: Sinovac Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Seasonal Influenza

Start date: 2022-11-27
Primary completion: 2023-01-24
Enrollment: 1260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.